Almac and VTU Technology have entered into a collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for half-life extension of proteins.   The alliance aims to provide several benefits to biopharma companies seeking fast-track protein expression and process development and subsequent site-specific protein modification. This integrated service platform combines VTU’s high-expression Pichia technology and s...